What Verdica's 799 score means for ALEXION PHARM
Alexion Pharm's composite score of 799 out of 850 places it in the "strong" performance band (740–799), indicating a pharmacy provider with solid regulatory standing and compliance history. This score reflects data aggregated from state board of pharmacy records, FDA oversight, and DEA compliance monitoring—the three primary regulatory channels that govern pharmacy operations in the United States.
A score in this range suggests that Alexion Pharm meets core licensing and operational requirements and has not triggered significant enforcement actions or compliance failures in the indexed regulatory record. For a business owner or consumer evaluating a pharmacy provider, a 799 score signals lower risk relative to providers in the "elevated" or "high risk" bands, but it is not a perfect score. The gap between 799 and the maximum of 850 reflects areas where regulatory data shows room for improvement or where sub-category performance lags behind category leaders.
Readers should interpret this score as a starting point for due diligence, not a substitute for direct verification. The score is data-driven and objective, but it captures only what regulators publicly document. It does not account for factors like customer service quality, pricing competitiveness, or specialized services unless those dimensions affect regulatory compliance.
How the sub-scores break down
Product Approval (850/850): This perfect sub-score indicates that Alexion Pharm's pharmaceutical products—or the products it distributes or dispenses—are fully approved by the FDA and compliant with all product authorization requirements. In the pharmacy industry, a perfect approval score means no indexed products are under recall, suspension, or regulatory scrutiny for manufacturing, labeling, or safety defects. This is the strongest possible indicator within this dimension.
Manufacturer Profile (720/850): This score of 720 is notably lower than the other two sub-scores and is the primary factor preventing a higher composite score. A manufacturer profile score reflects the regulatory history and quality systems associated with the entity's production or sourcing practices. A score in this range (below the "strong" threshold) typically indicates either historical compliance issues that have been resolved, less extensive third-party quality certifications, or a smaller track record in regulatory databases. It does not necessarily signal active violations, but it suggests regulators or compliance auditors have noted areas requiring attention or that the organization has not yet accumulated a lengthy clean compliance history in this dimension.
FDA Compliance (830/850): This high sub-score reflects strong adherence to FDA regulations governing pharmacy operations, product handling, and reporting. FDA compliance includes adherence to current Good Manufacturing Practice (cGMP), adverse event reporting, recall cooperation, and facility inspections. A score of 830 indicates Alexion Pharm has maintained good standing in these areas, with no major FDA enforcement actions or unresolved inspection findings in the indexed record.
What regulators track for pharmacy providers
State boards of pharmacy license and monitor individual pharmacies and pharmacy personnel, enforce state-level dispensing rules, and track disciplinary actions. FDA oversight centers on product quality, manufacturing standards, labeling accuracy, and safety monitoring. The DEA regulates controlled substance handling, storage, security, and record-keeping for pharmacies that dispense or distribute scheduled medications.
Verdica's scoring incorporates data on licensing status, inspection findings, warning letters, consent decrees, recalls, disciplinary actions, and any documented deficiencies in record-keeping or security protocols. Scores move lower when regulators document violations, repeated failures, or unresolved compliance gaps. Scores improve when providers resolve findings, maintain clean inspection histories, and demonstrate consistent adherence to evolving regulatory standards.
Bottom line
Alexion Pharm is a strong-performing pharmacy provider based on its 799 composite score, with particularly robust product approval and FDA compliance records. Before engaging, verify the manufacturer profile sub-score details directly with state boards of pharmacy and the FDA to understand what drove that dimension slightly lower, and confirm current licensing status independently.